Original paperRheumatoid arthritis and cancer risk
References (30)
- et al.
Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis
J Chron Dis
(1978) - et al.
Occurrence of malignant neoplasms in the Rochester, Minnesota, rheumatoid arthritis cohort
Am J Med
(1985) Cancer and rheumatoid arthritis: epidemiologic considerations
Am J Med
(1985)- et al.
Cancer in rheumatoid arthritis: a prospective long-term study of mortality
Am J Med
(1985) - et al.
Association of non-Hodgkin's lymphoma with rheumatoid arthritis [letter]
Am J Med
(1986) - et al.
Mortality among arthritics
J Chronic Dis
(1976) Incidence of neoplasms in patients with rheumatoid arthritis exposed to different treatment regimens
Am J Med
(1985)- et al.
Determinants of cell type in patients with cancer of the lungs
Chest
(1990) Rheumatoid arthritis
Immunol Ser
(1993)- et al.
Epidemiology of rheumatoid arthritis: update
Epidemiol Rev
(1990)
Potential role of Epstein-Barr virus in Sjögren's syndrome and rheumatoid arthritis
J Rheumatol Suppl
(1992)
Incidence of cancer among patients with rheumatoid arthritis
J Natl Cancer Inst
(1993)
Cited by (361)
Naringenin nanoparticles targeting cyclin B1 suppress the progression of rheumatoid arthritis-associated lung cancer by inhibiting fibroblast-to-myofibroblast transition
2024, International Journal of Biochemistry and Cell BiologyRheumatoid arthritis and risk of lung cancer: Meta-analysis and Mendelian randomization study
2021, Seminars in Arthritis and RheumatismCancer risk and tumour necrosis factor inhibitors in patients with inflammatory arthritis
2020, Pharmacological ResearchJAK-Inhibitors – A Story of Success and Adverse Events
2024, Open Access Rheumatology: Research and ReviewsThe safety of systemic Janus kinase inhibitors in atopic dermatitis: A systematic review and meta-analysis of randomized controlled trials
2024, Journal of the European Academy of Dermatology and Venereology
Copyright © 1996 Published by Elsevier Ltd.